Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Molecular and Cellular Neurosciences|March 8, 2008
Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathyStefan Fischer, Christoph Kleinschnitz, Marcus Müller, et al.Movement Disorders Clinical Practice|February 12, 2026
Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real-World, Monocentric, Observational Study and Critical ReviewJohannes Hartig, Lennert Sitzmann, Doreen Hartenstein, et al.Translational Neurodegeneration|December 2, 2025
Molecular glucose imaging reveals functional brain reconfiguration by subthalamic deep brain stimulation in Parkinsonian ratsJiazhi Chen, Ningfei Li, Muthuraman Muthuraman, et al.Neuromolecular Medicine|June 16, 2006
Role of immune cells in animal models for inherited peripheral neuropathiesChi Wang Ip, Antje Kroner, Stefan Fischer, et al.Neurobiology of Disease|November 11, 2008
The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathyAntje Kroner, Nicholas Schwab, Chi Wang Ip, et al.Molecular and Cellular Neurosciences|June 17, 2008
Origin of CD11b+ macrophage-like cells in the CNS of PLP-overexpressing mice: low influx of haematogenous macrophages and unchanged blood-brain-barrier in the optic nerveChi Wang Ip, Bianca Kohl, Christoph Kleinschnitz, et al.Experimental Neurology|November 18, 2021
Experimental deep brain stimulation in rodent models of movement disordersSusanne Knorr, Thomas Musacchio, Raik Paulat, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|February 7, 2019
Management of delirium in Parkinson's diseaseGeorg Ebersbach, Chi Wang Ip, Stephan Klebe, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 25, 2023
Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerationsMartin Regensburger, Chi Wang Ip, Zacharias Kohl, et al.Behavioural Brain Research|June 23, 2022
Temporal, spatial and molecular pattern of dopaminergic neurodegeneration in the AAV-A53T α-synuclein rat model of Parkinson's diseaseThomas Musacchio, Jing Yin, Fabian Kremer, et al.Pageof 8